Literature DB >> 12432262

Visual genotyping of a coat color tagged p53 mutant mouse line.

Binhai Zheng1, Hannes Vogel, Lawrence A Donehower, Allan Bradley.   

Abstract

The p53 knockout mouse has been widely used as a model in cancer research and other applications. Because neither homozygous nor heterozygous mutant p53 mice exhibit an overt phenotype, each animal requires laborious molecular genotyping. Here we describe a new p53 mutant mouse that is tagged with a tyrosinase coat color minigene. On an albino background, heterozygous tyrosinase-tagged p53 mutant mice exhibit a light tan coat color, while homozygous mutants display a darker brown coat color. Thus, by 8-10 days of age, mice with two, one, or no mutant p53 alleles are immediately distinguishable by their coat color, eliminating the time, costs, and errors associated with molecular genotyping. Moreover, the homozygous mutant p53-tyrosinase mice display a tumor incidence and spectrum virtually identical to previous p53 null mouse lines. Thus, tagging targeted mutations with such coat color markers provides a generally applicable genotyping method for embryonic stem cell-derived mice.

Entities:  

Mesh:

Year:  2002        PMID: 12432262     DOI: 10.4161/cbt.1.4.24

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  6 in total

1.  Induced mitotic recombination of p53 in vivo.

Authors:  Wei Wang; Madhuri Warren; Allan Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

2.  Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models.

Authors:  Tamara Terzian; Melissa Dumble; Farinaz Arbab; Christina Thaller; Lawrence A Donehower; Guillermina Lozano; Monica J Justice; Dennis R Roop; Neil F Box
Journal:  J Pathol       Date:  2011-06-14       Impact factor: 7.996

3.  A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.

Authors:  Vidya C Sinha; Lan Qin; Yi Li
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

4.  Hypertrophic chondrocyte-specific Col10a1 controlling elements in Cre recombinase transgenic studies.

Authors:  Jinnan Chen; Fangzhou Chen; Huiqin Bian; Qian Wang; Xiaojing Zhang; Lichun Sun; Junxia Gu; Yaojuan Lu; Qiping Zheng
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

6.  Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity.

Authors:  L van der Weyden; A G Rust; R E McIntyre; C D Robles-Espinoza; M del Castillo Velasco-Herrera; R Strogantsev; A C Ferguson-Smith; S McCarthy; T M Keane; M J Arends; D J Adams
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.